-
1
-
-
0023771584
-
Randomized, controlled trial of recombinant human alfa-interferon in patients with chronic hepatitis B
-
Hoofnagle JH, Peters M, Mullen KG et al. Randomized, controlled trial of recombinant human alfa-interferon in patients with chronic hepatitis B. Gastroenterology 1988; 95:1318-1325.
-
(1988)
Gastroenterology
, vol.95
, pp. 1318-1325
-
-
Hoofnagle, J.H.1
Peters, M.2
Mullen, K.G.3
-
2
-
-
0024384399
-
Randomized controlled trial of interferon alfa 2A (rbe) (Roferon-A) for the treatment of chronic hepatitis B virus (HBV) infection: Factors that influence response
-
Brook MG, McDonald JA, Karayiannis P et al. Randomized controlled trial of interferon alfa 2A (rbe) (Roferon-A) for the treatment of chronic hepatitis B virus (HBV) infection: factors that influence response. Gut 1989; 30: 1116-1122.
-
(1989)
Gut
, vol.30
, pp. 1116-1122
-
-
Brook, M.G.1
McDonald, J.A.2
Karayiannis, P.3
-
3
-
-
0024359014
-
A controlled trial of human lymphoblastoid interferon in chronic hepatitis B in Italy
-
Saracco G, Mazzella G, Rosina F et al. A controlled trial of human lymphoblastoid interferon in chronic hepatitis B in Italy. Hepatology 1989; 10: 336-341.
-
(1989)
Hepatology
, vol.10
, pp. 336-341
-
-
Saracco, G.1
Mazzella, G.2
Rosina, F.3
-
4
-
-
0024426417
-
Randomized controlled trial of lymphoblastoid interferon alfa in Europid men with chronic hepatitis B virus infection
-
Brook GM, Chan, Yap I et al. Randomized controlled trial of lymphoblastoid interferon alfa in Europid men with chronic hepatitis B virus infection. BMJ 1989; 299: 652-656.
-
(1989)
BMJ
, vol.299
, pp. 652-656
-
-
Brook, G.M.1
Chan2
Yap, I.3
-
5
-
-
0027378724
-
Effects of alpha-interferon treatment in patients with hepatitis B e antigen-positive chronic hepatitis B. A metaanalysis
-
Wong DKH, Cheung AM, O'Rourke K, Naylor CD, Detsky AS, Heathcote J. Effects of alpha-interferon treatment in patients with hepatitis B e antigen-positive chronic hepatitis B. A metaanalysis. Ann Intern Med 1993; 119: 312-323.
-
(1993)
Ann Intern Med
, vol.119
, pp. 312-323
-
-
Wong, D.K.H.1
Cheung, A.M.2
O'Rourke, K.3
Naylor, C.D.4
Detsky, A.S.5
Heathcote, J.6
-
6
-
-
0026695602
-
Long-term follow-up of heaptitis B chronic carriers who responded to interferon therapy
-
Carreno V, Castillo I, Molina J, Porres JC, Bartolome J. Long-term follow-up of heaptitis B chronic carriers who responded to interferon therapy. J Hepatol 1992; 15: 102-106.
-
(1992)
J Hepatol
, vol.15
, pp. 102-106
-
-
Carreno, V.1
Castillo, I.2
Molina, J.3
Porres, J.C.4
Bartolome, J.5
-
7
-
-
0025734569
-
Long-term remission of chronic hepatitis B after alpha-interferon therapy
-
Korenman J, Baker B, Waggoner J, Everhart JE, Di Bisceglie AM, Hoofnagle JH. Long-term remission of chronic hepatitis B after alpha-interferon therapy. Ann Intern Med 1991; 114: 629-634.
-
(1991)
Ann Intern Med
, vol.114
, pp. 629-634
-
-
Korenman, J.1
Baker, B.2
Waggoner, J.3
Everhart, J.E.4
Di Bisceglie, A.M.5
Hoofnagle, J.H.6
-
8
-
-
0028887880
-
Interferon alfa for chronic active hepatitis B. Long-term follow-up of 62 patients: Outcomes and predictors of response
-
Hope RL, Weltman M, Dingley J et al. Interferon alfa for chronic active hepatitis B. Long-term follow-up of 62 patients: outcomes and predictors of response. Med J Aust 1995; 162: 8-11.
-
(1995)
Med J Aust
, vol.162
, pp. 8-11
-
-
Hope, R.L.1
Weltman, M.2
Dingley, J.3
-
9
-
-
0027142488
-
Long-term follow-up of chronic hepatitis B patients treated with interferon alfa
-
Lok ASF, Chung HT, Liu VWS, Ma OCK. Long-term follow-up of chronic hepatitis B patients treated with interferon alfa. Gastroenterology 1993; 105: 1833-1838.
-
(1993)
Gastroenterology
, vol.105
, pp. 1833-1838
-
-
Lok, A.S.F.1
Chung, H.T.2
Liu, V.W.S.3
Ma, O.C.K.4
-
10
-
-
0016685783
-
Dane particles, DNA polymerase and e antigen in two distinct categories of heaptitis B antigen carriers
-
Nordenfeldt E, Kjellen L. Dane particles, DNA polymerase and e antigen in two distinct categories of heaptitis B antigen carriers. Intervirology 1975; 5: 225-232.
-
(1975)
Intervirology
, vol.5
, pp. 225-232
-
-
Nordenfeldt, E.1
Kjellen, L.2
-
11
-
-
0019522817
-
Seroconversion from hepatitis B e antigen to antibody in chronic type B hepatitis
-
Hoofnagle JH, Dusheiko GM, Seff LB, Jones EA, Waggoner JG, Bales ZB. Seroconversion from hepatitis B e antigen to antibody in chronic type B hepatitis. Ann Intern Med 1981; 94: 744-748.
-
(1981)
Ann Intern Med
, vol.94
, pp. 744-748
-
-
Hoofnagle, J.H.1
Dusheiko, G.M.2
Seff, L.B.3
Jones, E.A.4
Waggoner, J.G.5
Bales, Z.B.6
-
12
-
-
0018973172
-
Seroconversion from hepatitis B e antigen to anti-HBe in chronic hepatitis B virus infection
-
Realdi G, Alberti A, Rugge M et al. Seroconversion from hepatitis B e antigen to anti-HBe in chronic hepatitis B virus infection. Gastroenterology 1980; 79: 195-199.
-
(1980)
Gastroenterology
, vol.79
, pp. 195-199
-
-
Realdi, G.1
Alberti, A.2
Rugge, M.3
-
13
-
-
0027998132
-
Survival and prognostic factors in 366 patients with compensated cirrhosis type B: A multicenter study
-
Realdi G, Fattovich G, Hadziyannis S et al. Survival and prognostic factors in 366 patients with compensated cirrhosis type B: a multicenter study. J Hepatol 1994; 21: 656-666.
-
(1994)
J Hepatol
, vol.21
, pp. 656-666
-
-
Realdi, G.1
Fattovich, G.2
Hadziyannis, S.3
-
14
-
-
0026658646
-
Survival and prognostic indicators in hepatitis B surface antigen-positive cirrhosis of the liver
-
de Jongh FE, Janssen HLA, de Man RA, Hop WCJ, Schalm SW, van Blankenstein M. Survival and prognostic indicators in hepatitis B surface antigen-positive cirrhosis of the liver. Gastroenterology 1992; 103: 1630-1635.
-
(1992)
Gastroenterology
, vol.103
, pp. 1630-1635
-
-
De Jongh, F.E.1
Janssen, H.L.A.2
De Man, R.A.3
Hop, W.C.J.4
Schalm, S.W.5
Van Blankenstein, M.6
-
15
-
-
0028679078
-
Comparative study of three doses of interferon-α2a in chronic active hepatitis B
-
Thomas HC, Lok ASF, Carreno V et al. Comparative study of three doses of interferon-α2a in chronic active hepatitis B. J Viral Hep 1994; 1: 139-148.
-
(1994)
J Viral Hep
, vol.1
, pp. 139-148
-
-
Thomas, H.C.1
Lok, A.S.F.2
Carreno, V.3
-
16
-
-
0025611709
-
Problems in the management of chronic hepatitis B with interferon: Experience in a randomized, multicentre study
-
Realdi G, Fattovich G, Pastore G et al. Problems in the management of chronic hepatitis B with interferon: experience in a randomized, multicentre study. J Hepatol 1990; 11: 8129-8132.
-
(1990)
J Hepatol
, vol.11
, pp. 8129-8132
-
-
Realdi, G.1
Fattovich, G.2
Pastore, G.3
-
17
-
-
0027409202
-
To treat or not to treat? The judicious use of interferon alfa-2a for the treatment of chronic hepatitis B
-
Ryff JC. To treat or not to treat? The judicious use of interferon alfa-2a for the treatment of chronic hepatitis B. J Hepatol 1993; 17: S42-S46.
-
(1993)
J Hepatol
, vol.17
-
-
Ryff, J.C.1
-
18
-
-
0025981670
-
Natural history and prognostic factors for chronic hepatitis type B
-
Fattovich G, Brollo L, Giustina G et al. Natural history and prognostic factors for chronic hepatitis type B. Gut 1991; 32: 294-298.
-
(1991)
Gut
, vol.32
, pp. 294-298
-
-
Fattovich, G.1
Brollo, L.2
Giustina, G.3
-
19
-
-
0029893146
-
Long-term follow-up of HBeAg-positive patients treated with interferon alfa for chronic hepatitis B
-
Niederau C, Heintges T, Lange S et al. Long-term follow-up of HBeAg-positive patients treated with interferon alfa for chronic hepatitis B. N Engl J Med 1996; 334: 1422-1427.
-
(1996)
N Engl J Med
, vol.334
, pp. 1422-1427
-
-
Niederau, C.1
Heintges, T.2
Lange, S.3
|